Introduction
Gardner's syndrome (GS) comprises a triad of polyposis coli, osteomata and soft tissue tumours, with an autosomal dominant inheritance. Desmoid fibromatoses account for 45% of the soft tissue tumours' and occur in 3.5 to 29%2 ofpatients with GS.
Desmoid tumours are benign but locally invasive recurring neoplasms, consisting of mature fibroblasts within an extensive collagen matrix. Between 55 and 72% of these desmoid tumours are located within the mesentery. 3'4 There are at least 74 previously reported cases of mesenteric desmoid tumours associated with GS2'5'-excluding double citations. In patients with GS, they usually develop after surgical procedures, such as pancolectomy. '6 The extensive proliferative nature of the mesenteric tumour may lead to ureteric or intestinal obstruction or small bowel infarction. The tumours are difficult to treat, as they usually recur following resection. Several forms of drug treatment have therefore been tried. In this article, we report our experience ofdrug treatment in one patient and review previously reported experience in medical treatment of mesenteric desmoid tumours in Gardner's syndrome.
Case report
In August 1983, a 29 year old white female presented with an 18-month history of intermittent diarrhoea containing blood and mucus. Polyposis was diagnosed on endoscopy and she was treated with pancolectomy and ileorectal anastomosis. In March 1985 she developed amenorrhoea, galactorrhoea and abdominal distension at which time she stopped taking a combined oral contraceptive. In May 1985, she again presented with lower abdominal colic and a dull pain in both flanks relieved by the frequent passage of normal stool. A palpable mass in the right iliac fossa was confirmed by ultrasonography and on computed tomography. Upper and lower gastrointestinal endoscopy revealed adenomatous polyps in the stomach and at the ileorectal anastomosis. Laparotomy in May 1985 revealed a firm, white mass attached to the anterior abdominal wall and to the small bowel mesentery. A retroperitoneal tumour extended from the fourth part of the duodenum to the pelvic brim, and surrounded the superior mesenteric vessels. The tumour was not resectable. Biopsy revealed a desmoid tumour, remarkable only for the presence of eosinophils within the collagen matrix. Post-operative examination revealed a firm, fixed pelvic mass the size of a 20 week pregnancy; a pedunculated cutaneous polyp on the occiput (5 x 7 mm); an elevated soft tissue mass above the left mastoid process (3 x 5 mm) and over the spine extending from T1O to LI (8 x 3 cm). Many new small (2 to 4 mm) maculopapular lesions were noted on the upper limbs, trunk and neck; the patient stated that these started as vesicular lesions which became pigmented and encrusted. Plain radiography showed an osteoma on the occiput (Figure 1 ) and in the mandible. A computed tomographic (CT) scan of the abdomen confirmed the surgical findings, and has been used to monitor treatment. CT scan of the head revealed no abnormality of the brain. Mesenteric and abdominal wall desmoid formation appears to be induced by surgical trauma and there is up to a 50% recurrence rate despite wide resection.'O Harvey,9 Naylor23 and Nance 6 recommend that resection of mesenteric desmoid tumours be avoided regardless of tumour size due to stimulation oftumour growth and involvement of major local structures. complexity of adequate excision of mesenteric desmoids and frequency ofrecurrences, surgery should be reserved for relief of symptomatic obstructions. Occasional successful resection without recurrence has been reported,13'24 and one recent editorial considered surgery the only appropriate treatment. 25 Desmoid tumours have a 4% overall spontaneous regression rate.26 There have been five reported cases of spontaneous remission of desmoid tumours26'27 but only one of these was associated with GS or FPC. '9 It is difficult to assess the efficacy of different drug treatments for mesenteric desmoid tumours because of differences in clinical assessment, in therapeutic combinations and in the quantitation of response, and because of the small numbers involved in each report. The treatments that have been reported to cause at least partial regression ofmesenteric desmoid tumours in GS and the experiences with each drug are summarized in Table I .
The rationale for endocrine therapy of desmoid tumours is based on the probable hormonal influence upon their growth. In Gardner's syndrome, desmoid tumours seem to have developed after pregnancy" 9'22 and following exposure to oral contraceptives.29 '30 Oestrogens appear to stimulate growth,28'" and in particular a predominance of oestrogen over progesterone. 26 Oestrogens have produced fibrous tumours in rats whilst progesterone inhibited their development.3' In desmoid tumours not specifically associated with FPC, progestogens produced a 72% partial response rate (8 of 11 patients). 30 Oestrogen receptors have been found in the cytosol fraction of desmoid tumours from premenopausal women,26 and in three of four desmoid tumours, Reitamo demonstrated the presence of oestradiol receptors whilst progesterone receptors were absent. 32 Irradiation of abdominal desmoid tumours has proved successful occasionally,"' 4 but perhaps only by inducing menopause since only women receiving total abdominal radiation respond, and male patients do not respond.2228 In patients with extra-abdominal desmoid tumours unassociated with GS, however, prolonged megavoltage irradiation (greated than 50 gray for up to two years) has produced a 59% complete and 18% partial response rate in a series of 17 patients. 3 Our patient has gastric and rectal polyps following pancolectomy. Extracolonic polyps can be found in found a 100-fold increase above the age specific rate in the incidence of rectal carcinoma in patients who had undergone colectomy with ileorectal anastomosis followed by periodic removal of rectal polyps; the prevalence ranged from 5% at 5-year follow-up to 59% at 23 years among 178 patients. He suggested that rectal cancer might arise in patients with polyposis de novo without malignant transformation of existent rectal polyps. Fulguration of rectal polyps would therefore not decrease the risk of rectal carcinoma. Harvey,9 however, recommended conservative local removal of rectal polyps.
No case of malignant desmoid tumour has been reported28 after careful histopathological differentiation from fibrosarcoma.2 One patient had developed a fibrosarcoma within a mesenteric desmoid tumour 7 years after extensive irradiation. 22 In summary, mesenteric desmoid tumours are a common, and sometimes troublesome feature of Gardner's syndrome. They usually follow abdominal surgery such as colectomy for concomitant polyposis, and further surgery is seldom curative. Oestrogencontaining oral contraceptives and pregnancy may stimulate tumour growth in women, and laparoscopic sterilization is probably best avoided lest it induce further tumour growth. The anti-oestrogen tamoxifen and progestogens may inhibit tumour proliferation, and surgical intervention should be reserved for relief of inevitable intestinal or ureteral obstructions.
